Aktie KREBSBIO KREBS BIOCHEMICALS & INDUSTRIES LIMITED
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Krebs Biochemicals & Industries Limited NSE India S.E.

Aktien

KREBSBIO

INE268B01013

KREBSBIO

Verzögert NSE India S.E.
Andere Börsenplätze
 13:43:54 01.07.2024 		% 5 Tage % 1. Jan.
73.45 INR +3.52% Intraday Chart für Krebs Biochemicals & Industries Limited +4.17% -6.25%
21.05. Krebs Biochemicals & Industries Limited ernennt Rakesh Kalbate zum Company Secretary/Compliance Officer CI
21.05. Krebs Biochemicals & Industries Limited meldet die Ergebnisse für das vierte Quartal und das Gesamtjahr bis zum 31. März 2024 CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Krebs Biochemicals & Industries Limited Appoints Rakesh Kalbate as Company Secretary/Compliance Officer
Krebs Biochemicals & Industries Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024
Krebs Biochemicals & Industries Limited Announces Resignation of Keyur Doshi as Company Secretary, Compliance Officer
Krebs Biochemicals & Industries Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
Krebs Biochemicals & Industries Limited Appoints Keyur Doshi as Company Secretary, Compliance Officer
Andhra Pradesh Pollution Control Board Orders Production Halt at Krebs Biochemicals Plant
Krebs Biochemicals & Industries Limited Announces Resignation of Rohit Taparia as Company Secretary and Compliance Officer
Krebs Biochemicals & Industries Limited Reports Earnings Results for the First Quarter Ended June 30, 2023
Krebs Biochemicals & Industries Limited Approves Resignation of Mr. Pabitrakumar Kalipada Bhattacharya as Managing Director
Krebs Biochemicals Limited Announces Executive Changes, Effective 10 August 2023
Krebs Biochemicals Trims Net Loss in Fiscal Q4
Krebs Biochemicals & Industries Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023
Krebs Biochemicals Names New CFO
Krebs Biochemicals & Industries Limited Approves Appointment of Rohit Taparia as Company Secretary and Compliance Officer
Krebs Biochemicals & Industries Limited Approves CFO Changes
Krebs Biochemicals & Industries Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022
Krebs Biochemicals & Industries Limited Auditor Raises 'Going Concern' Doubt
Krebs Biochemicals & Industries Limited Reports Earnings Results for the First Quarter Ended June 30, 2022
Taruni Banda Resigns as Company Secretary and Compliance Officer of Krebs Biochemicals & Industries Limited, Effective from August 6, 2022
Krebs Biochemicals & Industries : Financial Result Updates
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. KREBSBIO Aktie
  4. KREBSBIO Aktie
  5. Nachrichten Krebs Biochemicals & Industries Limited
  6. Andere Sprachen